Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

8.87
-0.0400-0.45%
Volume:80.88K
Turnover:723.40K
Market Cap:1.41B
PE:-7.71
High:9.09
Open:9.00
Low:8.82
Close:8.91
Loading ...

Ocular Therapeutix Q1 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.70M Miss $16.83M Estimate

Benzinga
·
05 May

BRIEF-Ocular Therapeutix Q1 EPS USD -0.38 Vs. IBES Estimate USD -0.29

Reuters
·
05 May

Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights

THOMSON REUTERS
·
05 May

Ocular Therapeutix Q1 EPS USD -0.38 VS. Ibes Estimate USD -0.29

THOMSON REUTERS
·
05 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 May

Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for

Zacks
·
29 Apr

Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences

GlobeNewswire
·
29 Apr

Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025

GlobeNewswire
·
28 Apr

Piper Sandler Keeps Their Buy Rating on Ocular Therapeutix (OCUL)

TIPRANKS
·
21 Apr

Investors bid Ocular Therapeutix (NASDAQ:OCUL) up US$202m despite increasing losses YoY, taking three-year CAGR to 24%

Simply Wall St.
·
15 Apr

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
12 Apr

Ocular Therapeutix Initiated at Outperform by William Blair

Dow Jones
·
08 Apr

William Blair Initiates Ocular Therapeutix With Outperform Rating

MT Newswires Live
·
08 Apr

Ocular Therapeutix initiated with an Outperform at William Blair

TIPRANKS
·
08 Apr

Top Premarket Decliners

MT Newswires Live
·
02 Apr

Ocular Therapeutix™ to Participate in Two Investor Conferences in April

GlobeNewswire
·
31 Mar

Ocular Therapeutix Initiated at Outperform by RBC Capital

Dow Jones
·
18 Mar

Ocular Therapeutix (OCUL) Gets a Buy from RBC Capital

TIPRANKS
·
18 Mar

Why Ocular Therapeutix Was Bumping Higher This Week

Motley Fool
·
14 Mar

Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside

Benzinga
·
12 Mar